Elahere was approved for FRα-positive, platinum-resistant gynecologic cancers, showing better outcomes than chemotherapy in the MIRASOL trial. Udenyca's on-body administration offers a new method for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results